Skip to main content
. 2014 Jun 26;8(3):1087–1089. doi: 10.3892/ol.2014.2293

Figure 2.

Figure 2

BXPC-3 cell viability detected using the Cell Counting Kit-8 assay following treatment with shikonin (0, 1, 2.5 and 5 μmol/l) after (A) 24 h and (B) 48 h. *P<0.05 and **P<0.01, vs. the control group.